Skip to main content

3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one

ADVERTISEMENT
Identification
Molecular formula
C10H16Br2N2O2
CAS number
n/a
IUPAC name
3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one
State
State

The compound is a solid at room temperature.

Melting point (Celsius)
122.50
Melting point (Kelvin)
395.65
Boiling point (Celsius)
395.20
Boiling point (Kelvin)
668.35
General information
Molecular weight
358.05g/mol
Molar mass
358.0500g/mol
Density
1.6200g/cm3
Appearence

This compound is typically a crystalline solid. It may appear as a white to lightly-colored powder depending on purity.

Comment on solubility

Solubility of 3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one

The compound 3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one with the chemical formula C10H16Br2N2O2 exhibits particular solubility characteristics that are intriguing in the realm of chemical sciences. Understanding its solubility is vital for practical applications, such as drug formulation or chemical synthesis.

In general, the solubility of this compound can be influenced by several key factors:

  • Polarity: The presence of bromine and nitrogen functionalities suggests a moderate polarity, which can enhance solubility in polar solvents.
  • Hydrogen Bonding: The carbonyl group (–C=O) in the structure can participate in hydrogen bonding, which typically increases solubility in solvents capable of offering hydrogen bonds.
  • Hydrophobic Interactions: The hydrophobic propanoyl and piperazine moieties may limit solubility in highly polar solvents and could lead to better solubility in organic solvents.

While this compound may dissolve to some extent in water due to its nitrogen and carbonyl groups, it is likely to have better solubility in organic solvents such as ethanol and dimethyl sulfoxide (DMSO). As a rule of thumb, compounds like this tend to follow the adage of "like dissolves like," thereby indicating that a mix of polar and non-polar solvents would be most effective in achieving optimal solubility.

In summary, the solubility of 3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one is a complex interplay of its structure and the properties of the solvent. Care should be taken to consider both polar and non-polar environments when investigating its dissolution behavior.

Interesting facts

Interesting Facts about 3-Bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one

This unique compound features a sophisticated structure that makes it a topic of great interest in the fields of medicinal and organic chemistry. Here are some fascinating points to consider:

  • Complex Structure: The presence of a piperazine ring along with bromopropanoyl groups contributes to its intriguing functionality, which can be explored for various applications in pharmaceuticals.
  • Potential Pharmaceutical Applications: Compounds like this one are often investigated for their potential in drug development, particularly due to the presence of bromine atoms. Brominated compounds can exhibit unique biological activities, making them valuable in medicinal chemistry.
  • Mechanisms of Action: The incorporation of the piperazine moiety in the structure often suggests involvement in receptor binding or enzyme inhibition, potentially leading to research into its effects on neurotransmitter systems.
  • Chirality and Isomerism: As a compound containing multiple chiral centers, the stereochemistry of this molecule may affect its biological activity and interactions in living systems, a significant consideration in drug design.
  • Research Importance: The synthesis and study of compounds like this one could pave the way for new therapeutic agents in treating various diseases, providing new avenues for medical research.

In summary, 3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one exemplifies the convergence of complex organic chemistry and potential real-world applications, making it a noteworthy subject for investigation and study in the scientific community.

Synonyms
pipobroman
54-91-1
Vercyte
Amedel
1,1'-(Piperazine-1,4-diyl)bis(3-bromopropan-1-one)
Pipobromanum
1,4-Bis(3-bromopropionyl)piperazine
A-8103
Piperazine, 1,4-bis(3-bromo-1-oxopropyl)-
NSC-25154
N,N-Bis-(3-bromopropionyl)-piperazine
NSC25154
A 1803
3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one
Pipobromanum [INN-Latin]
Piperazine, 1,4-bis(3-bromopropionyl)-
N,N'-Bis(3-bromopropionyl)piperazine
CCRIS 2753
HSDB 3249
UNII-6Q99RDT97R
1,4-Bis(3-bromopropanoyl)piperazine
NSC 25154
BRN 0749866
6Q99RDT97R
CHEBI:8242
DTXSID7023485
AI3-50113
Pipobroman [USAN:USP:INN]
DTXCID503485
NCGC00095048-01
Pipobromanum (INN-Latin)
A 8103
PIPOBROMAN (MART.)
PIPOBROMAN [MART.]
Pipobroman (USAN:USP:INN)
1,1'-piperazine-1,4-diylbis(3-bromopropan-1-one)
CAS-54-91-1
SR-05000001858
VERCYTE (TN)
Pipobroman (JAN/USAN/INN)
MFCD00866372
Spectrum_001727
PIPOBROMAN [MI]
PIPOBROMAN [INN]
PIPOBROMAN [JAN]
Spectrum2_000912
Spectrum3_001047
Spectrum5_001135
PIPOBROMAN [HSDB]
PIPOBROMAN [USAN]
PIPOBROMAN [VANDF]
SCHEMBL4889
CHEMBL1585
PIPOBROMAN [WHO-DD]
BSPBio_002574
KBioSS_002207
DivK1c_000799
SPECTRUM1503393
SPBio_000784
GTPL7271
PIPOBROMAN [ORANGE BOOK]
HMS502H21
KBio1_000799
KBio2_002207
KBio2_004775
KBio2_007343
KBio3_001794
NINDS_000799
NJBFOOCLYDNZJN-UHFFFAOYSA-N
HMS1922C10
HMS2093E11
Pharmakon1600-01503393
WLN: T6N DNTJ AV2E DV2E
BCP31516
Tox21_111402
CCG-39748
NSC758461
Piperazine,4-bis(3-bromopropionyl)-
s4447
1, 4-Bis(3-bromopropionyl)piperazine
AKOS016010321
Tox21_111402_1
CS-5085
DB00236
DS-4654
NSC-758461
1,4-Bis(3-bromopropanoyl)piperazine #
IDI1_000799
NCGC00095048-02
NCGC00095048-03
NCGC00095048-04
NCGC00095048-06
DA-56889
HY-16398
NCI60_002008
Piperazine,4-bis(3-bromo-1-oxopropyl)-
NS00008206
C07362
D00467
W18797
AB00052352-02
AB00052352_03
EN300-7415033
SR-05000001858-1
SR-05000001858-2
BRD-K15656090-001-04-0
BRD-K15656090-001-06-5
Q15366704
1,1'-(1,4-Piperazinediyl)bis[3-bromo-1-propanone];
Vercyte;NSC-25154;1,4-Bis(3-bromo-1-oxopropyl)piperazine